Acino Pharma is a finished-dose manufacturer based in Switzerland. It appears in 199 regulatory filings across 15 regulators, without an active US DMF or CEP on file. Its filings concentrate with NMRC (NA), SFDA (Saudi Arabia) and RAMA (GE). Its GMP standing is certified by EMA and NAFDAC (NG). Customs aggregates show $531K of exports covering 6 molecules to 1 destination in 2022.
| Site | FDA FEI |
|---|---|
| Liesberg, United Arab Emirates | Not on file |
| Aesch Bl, Switzerland | Not on file |
| Liesberg, Switzerland | Not on file |
| Liesberg Switzerland, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NMRC (NA) | 50 | None |
| SFDA (Saudi Arabia) | 39 | None |
| RAMA (GE) | 31 | None |
| MINSA (CR) | 18 | None |
| ARCSA (EC) | 16 | None |
| EMA | 10 | 2 |
| NAFDAC (NG) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2022 | Not reported | $531K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Acino Pharma comes back tiered against every other supplier able to file there.
Start for free